v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Beginning balance (in shares) at Dec. 31, 2023   28.2        
Balance, beginning at Dec. 31, 2023 $ 1,273 $ 0 $ 1,820 $ 498 $ (118) $ (927)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 65     65    
Other comprehensive loss (6)       (6)  
Stock-based compensation charges 5   5      
Dividends declared (19)     (19)    
Net settlement on vesting of equity awards (in shares)   0.1        
Net settlement on vesting of equity awards (12)   (12)      
Employee stock purchase plan 1   1      
Exercise of stock options 1   1      
Ending balance (in shares) at Mar. 31, 2024   28.3        
Balance, ending at Mar. 31, 2024 1,308 $ 0 1,815 544 (124) (927)
Beginning balance (in shares) at Dec. 31, 2023   28.2        
Balance, beginning at Dec. 31, 2023 1,273 $ 0 1,820 498 (118) (927)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 135          
Ending balance (in shares) at Jun. 30, 2024   28.4        
Balance, ending at Jun. 30, 2024 1,362 $ 0 1,821 595 (127) (927)
Beginning balance (in shares) at Mar. 31, 2024   28.3        
Balance, beginning at Mar. 31, 2024 1,308 $ 0 1,815 544 (124) (927)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 70     70    
Other comprehensive loss (3)       (3)  
Stock-based compensation charges 4   4      
Dividends declared (19)     (19)    
Employee stock purchase plan 1   1      
Exercise of stock options (in shares)   0.1        
Exercise of stock options 1   1      
Ending balance (in shares) at Jun. 30, 2024   28.4        
Balance, ending at Jun. 30, 2024 $ 1,362 $ 0 1,821 595 (127) (927)
Beginning balance (in shares) at Dec. 31, 2024 28.4 28.4        
Balance, beginning at Dec. 31, 2024 $ 1,396 $ 0 1,832 633 (142) (927)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (18)     (18)    
Stock-based compensation charges 6   6      
Dividends declared (20)     (20)    
Net settlement on vesting of equity awards (in shares)   0.1        
Net settlement on vesting of equity awards (7)   (7)      
Employee stock purchase plan 1   1      
Ending balance (in shares) at Mar. 31, 2025   28.5        
Balance, ending at Mar. 31, 2025 $ 1,358 $ 0 1,832 595 (142) (927)
Beginning balance (in shares) at Dec. 31, 2024 28.4 28.4        
Balance, beginning at Dec. 31, 2024 $ 1,396 $ 0 1,832 633 (142) (927)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) $ (53)          
Ending balance (in shares) at Jun. 30, 2025 33.2 33.2        
Balance, ending at Jun. 30, 2025 $ 1,911 $ 0 2,423 540 (125) (927)
Beginning balance (in shares) at Mar. 31, 2025   28.5        
Balance, beginning at Mar. 31, 2025 1,358 $ 0 1,832 595 (142) (927)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (35)     (35)    
Other comprehensive loss 17       17  
Stock-based compensation charges 6   6      
Dividends declared (20)     (20)    
Employee stock purchase plan 1   1      
Issuance of common stock for H&E acquisition (in shares)   4.7        
Issuance of common stock for H&E acquisition $ 584   584      
Ending balance (in shares) at Jun. 30, 2025 33.2 33.2        
Balance, ending at Jun. 30, 2025 $ 1,911 $ 0 $ 2,423 $ 540 $ (125) $ (927)